Molecular and Genetic Analysis of Lung Cancer

NCT03029325 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2024-11-29

No results posted yet for this study

Summary

Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • David C Christiani, MD · Harvard TH Chan School of Public Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1993-06-30
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03029325 on ClinicalTrials.gov